Cargando…

Engineered human mesenchymal stem cells for neuroblastoma therapeutics

Drug-resistant neuroblastoma remains a major challenge in paediatric oncology and novel and less toxic therapeutic approaches are urgently needed to improve survival and reduce the side effects of traditional therapeutic interventions. Mesenchymal stem cells (MSCs) are an attractive candidate for ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieddu, Valentina, Piredda, Roberta, Bexell, Daniel, Barton, Jack, Anderson, John, Sebire, Neil, Kolluri, Krishna, Janes, Sam M., Karteris, Emmanouil, Sala, Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549104/ https://www.ncbi.nlm.nih.gov/pubmed/31115546 http://dx.doi.org/10.3892/or.2019.7152

Ejemplares similares

Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy
por: Kolluri, Krishna K., et al.
Publicado: (2013)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
por: Yuan, Zhengqiang, et al.
Publicado: (2016)

Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2015)

Repurposing a psychoactive drug for children with cancer: p27(Kip1)-dependent inhibition of metastatic neuroblastomas by Prozac
por: Bibbo’, Sandra, et al.
Publicado: (2020)

TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2017)

Patient-derived models: Advanced tools for precision medicine in neuroblastoma
por: Aaltonen, Kristina, et al.
Publicado: (2023)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014)

Anti-tumor effects of rigosertib in high-risk neuroblastoma
por: Radke, Katarzyna, et al.
Publicado: (2021)

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
por: Capone, Emily, et al.
Publicado: (2020)

Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis
por: Olm, Franziska, et al.
Publicado: (2021)

Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications
por: Hochheuser, Caroline, et al.
Publicado: (2021)

Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples
por: Barton, Jack, et al.
Publicado: (2019)

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
por: Valind, Anders, et al.
Publicado: (2023)

Non-Invasive Longitudinal Bioluminescence Imaging of Human Mesoangioblasts in Bioengineered Esophagi
por: Crowley, Claire, et al.
Publicado: (2019)

Integrative discovery of treatments for high-risk neuroblastoma
por: Almstedt, Elin, et al.
Publicado: (2020)

Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma
por: Sime, Wondossen, et al.
Publicado: (2020)

ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
por: Houghton-Gisby, Jack, et al.
Publicado: (2022)

Amplification efficiency and thermal stability of qPCR instrumentation: Current landscape and future perspectives
por: ROGERS-BROADWAY, KARLY-RAI, et al.
Publicado: (2015)

Deciphering the Role of microRNA Mediated Regulation of Coronin 1C in Glioblastoma Development and Metastasis
por: Mustafov, Denis, et al.
Publicado: (2023)

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
por: Vallath, Sabari, et al.
Publicado: (2016)

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma
por: Ishii, Yuki, et al.
Publicado: (2021)

Dynamic Changes in Microvascular Density Can Predict Viable and Non-Viable Areas in High-Risk Neuroblastoma
por: Privitera, Laura, et al.
Publicado: (2023)

Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
por: Persson, Camilla U., et al.
Publicado: (2017)

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
por: Mañas, Adriana, et al.
Publicado: (2022)

Genetically modified mesenchymal stromal cells in cancer therapy
por: Sage, Elizabeth K., et al.
Publicado: (2016)

Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
por: Siaw, Joachim T., et al.
Publicado: (2021)

Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function
por: Ollé Hurtado, Marina, et al.
Publicado: (2019)

Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel
por: van Wezel, Esther M., et al.
Publicado: (2019)

ENGINEERING T CELLS TARGETING GPC2 FOR TREATING NEUROBLASTOMA
por: Quan, Alex, et al.
Publicado: (2023)

Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma: FUNCTIONAL AND THERAPEUTIC IMPLICATIONS
por: Corvetta, Daisy, et al.
Publicado: (2013)

Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
por: Privitera, Laura, et al.
Publicado: (2023)

Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study
por: Alizzi, Zena, et al.
Publicado: (2023)

Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma
por: Pandey, Gaurav Kumar, et al.
Publicado: (2023)

Ferroptosis Inducers Kill Mesenchymal Stem Cells Affected by Neuroblastoma
por: Li, Xiangze, et al.
Publicado: (2023)

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas
por: Cantilena, Sandra, et al.
Publicado: (2011)

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
por: Braekeveldt, Noémie, et al.
Publicado: (2015)

The effect of online and in-person team-based learning (TBL) on undergraduate endocrinology teaching during COVID-19 pandemic
por: Anas, Shafeena, et al.
Publicado: (2022)

Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19
por: Kyrou, Ioannis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aiuotvqmqn5b9v8liq8ucue0em